牛叉诊股

[{"date":"2026.06.30","stock":"-2.10","trade":"-1.27","ind":"2.48"},{"date":"2026.06.29","stock":"4.65","trade":"5.87","ind":"0.19"},{"date":"2026.06.26","stock":"-3.47","trade":"-4.86","ind":"-3.44"},{"date":"2026.06.25","stock":"-2.48","trade":"-1.35","ind":"1.82"},{"date":"2026.06.24","stock":"-1.38","trade":"-0.89","ind":"1.24"},{"date":"2026.06.23","stock":"2.33","trade":"3.68","ind":"-3.17"},{"date":"2026.06.22","stock":"0.76","trade":"0.07","ind":"2.13"},{"date":"2026.06.18","stock":"0.85","trade":"0.66","ind":"0.94"},{"date":"2026.06.17","stock":"-1.91","trade":"-1.16","ind":"1.31"},{"date":"2026.06.16","stock":"-0.58","trade":"-0.99","ind":"0.93"},{"date":"2026.06.15","stock":"-0.33","trade":"0.15","ind":"3.79"},{"date":"2026.06.12","stock":"1.93","trade":"2.07","ind":"0.75"},{"date":"2026.06.11","stock":"-1.49","trade":"-1.24","ind":"-0.68"},{"date":"2026.06.10","stock":"1.94","trade":"-0.14","ind":"-2.06"},{"date":"2026.06.09","stock":"0.50","trade":"0.45","ind":"3.02"},{"date":"2026.06.08","stock":"-3.12","trade":"-2.49","ind":"-3.22"},{"date":"2026.06.05","stock":"2.04","trade":"0.25","ind":"-2.21"},{"date":"2026.06.04","stock":"-2.16","trade":"-1.80","ind":"-0.27"},{"date":"2026.06.03","stock":"-2.34","trade":"-1.10","ind":"0.73"},{"date":"2026.06.02","stock":"-0.54","trade":"-2.06","ind":"1.63"},{"date":"2026.06.01","stock":"1.50","trade":"0.40","ind":"-1.51"}]

山河药辅,深证成指,化学制药指数

压力支撑

该股压力位为11.73元，支撑位为11.43元。

[{"text":"\u538b\u529b\u4f4d","value":"11.73","date":1782748800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.43","date":1782748800,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.3资金面打败了28%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体无进出。

更新时间：06月30日 20:30

机构今日流向(万元)	-1563.78	机构5日流向(万元)	-226.76
机构10日流向(万元)	-1373.79	机构20日流向(万元)	-7392.12

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加1140.20万股，其中基金净减仓5家，主力净增仓52家，请投资者中长期谨慎为宜。

截止2025-12-31，共82家主力机构（基金80家，一般法人2家），持仓量总计3505.81万股，占流通A股17.65%
其中，基金持仓与2025-06-30相比：
增仓：3家，增持 41.38万股
减仓：8家，减持 27.18万股
新出现在主力名单中：69家，持有1278.23万股
从主力名单中消失：17家，原持有111.06万股

消息面诊股

诊断结果：5.8消息面打败了31%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2026-06-05
一般消息	股东大会	年度股东大会	2026-04-23
利好	分红转增	10派3元(含税)	2026-04-23
重大利好	业绩预告	业绩大幅上升	2026-01-14
一般消息	资产重组	公司股权转让	2025-10-23
一般消息	分红转增	不分配不转增	2025-08-27
一般消息	高管变动	逝世	2025-08-26
一般消息	高管变动	取消监事会	2025-08-18

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	1条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：2.5行业面打败了45%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.06.30","price":"2.48","value":"-1.27"},{"date":"2026.06.29","price":"0.19","value":"5.87"},{"date":"2026.06.26","price":"-3.44","value":"-4.86"},{"date":"2026.06.25","price":"1.82","value":"-1.35"},{"date":"2026.06.24","price":"1.24","value":"-0.89"},{"date":"2026.06.23","price":"-3.17","value":"3.68"},{"date":"2026.06.22","price":"2.13","value":"0.07"},{"date":"2026.06.18","price":"0.94","value":"0.66"},{"date":"2026.06.17","price":"1.31","value":"-1.16"},{"date":"2026.06.16","price":"0.93","value":"-0.99"},{"date":"2026.06.15","price":"3.79","value":"0.15"},{"date":"2026.06.12","price":"0.75","value":"2.07"},{"date":"2026.06.11","price":"-0.68","value":"-1.24"},{"date":"2026.06.10","price":"-2.06","value":"-0.14"},{"date":"2026.06.09","price":"3.02","value":"0.45"},{"date":"2026.06.08","price":"-3.22","value":"-2.49"},{"date":"2026.06.05","price":"-2.21","value":"0.25"},{"date":"2026.06.04","price":"-0.27","value":"-1.80"},{"date":"2026.06.03","price":"0.73","value":"-1.10"},{"date":"2026.06.02","price":"1.63","value":"-2.06"},{"date":"2026.06.01","price":"-1.51","value":"0.40"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	花园生物	77.82%	4.99%	6.0分
2	富祥股份	43.99%	-0.89%	5.8分
3	百利天恒	37.95%	16.48%	6.4分
4	-	34.82%	16.17%	分
5	海思科	32.34%	24.68%	7.4分
6	灵康药业	31.55%	1.98%	6.8分
7	贝达药业	27.41%	11.52%	6.9分
8	科源制药	22.91%	1.75%	5.0分
9	艾力斯	22.41%	24.54%	7.2分
10	赛分科技	20.27%	13.16%	6.9分
11	海南海药	19.38%	22.30%	5.5分
12	泽璟制药	17.10%	30.04%	6.9分
13	纳微科技	15.63%	2.73%	6.8分
14	前沿生物	14.75%	16.18%	6.3分
15	金石亚药	12.53%	12.41%	5.7分
16	海欣股份	11.51%	-7.30%	5.8分
17	圣诺生物	11.28%	7.13%	6.5分
18	亨迪药业	11.20%	0.27%	6.0分
19	司太立	10.40%	11.29%	5.6分
20	百济神州	8.52%	11.67%	6.9分
21	科伦药业	6.82%	3.67%	6.1分
22	广生堂	6.10%	15.65%	5.0分
23	恒瑞医药	5.84%	6.25%	6.8分
24	-	5.18%	0.67%	分
25	海辰药业	5.14%	-9.70%	5.8分
26	兴齐眼药	5.02%	8.00%	5.6分
27	石药创新	4.93%	10.74%	5.7分
28	天宇股份	4.73%	-6.28%	5.9分
29	新华制药	4.42%	5.43%	5.6分
30	键凯科技	2.77%	6.82%	6.1分
31	吉贝尔	2.11%	0.75%	5.9分
32	复旦张江	2.07%	-1.34%	5.9分
33	华特达因	1.94%	0.71%	5.5分
34	共同药业	1.74%	-11.26%	5.3分
35	海正药业	1.71%	2.12%	5.6分
36	-	0.21%	1.67%	分
37	双鹭药业	0.00%	7.04%	5.4分
38	翰宇药业	-0.50%	-0.90%	5.0分
39	普洛药业	-0.83%	-0.83%	5.7分
40	华东医药	-1.26%	-2.77%	5.2分
41	东诚药业	-1.80%	-1.57%	5.8分
42	千红制药	-1.90%	4.90%	5.3分
43	丽珠集团	-1.97%	-2.13%	5.0分
44	复星医药	-2.26%	0.94%	5.7分
45	莱美药业	-2.47%	7.77%	4.9分
46	信立泰	-2.77%	2.87%	5.7分
47	泰恩康	-2.94%	4.97%	5.6分
48	微芯生物	-3.16%	3.42%	6.3分
49	奥锐特	-3.57%	-4.78%	4.8分
50	益方生物	-3.69%	6.57%	5.9分
51	诚意药业	-3.84%	-1.57%	5.2分
52	舒泰神	-3.92%	5.22%	5.4分
53	威尔药业	-3.94%	-7.82%	4.8分
54	奥赛康	-4.15%	3.26%	6.6分
55	-	-4.50%	-5.17%	分
56	凯因科技	-4.56%	-0.06%	4.6分
57	新和成	-4.79%	-4.47%	4.8分
58	京新药业	-4.80%	1.63%	5.4分
59	华润双鹤	-5.03%	-3.49%	4.6分
60	盟科药业	-5.23%	-2.16%	5.6分
61	中关村	-5.32%	-3.99%	5.3分
62	ST惠程	-5.35%	-1.39%	3.9分
63	力生制药	-5.53%	-2.54%	5.1分
64	健康元	-5.99%	-2.38%	4.6分
65	仙琚制药	-6.06%	-3.01%	4.7分
66	-	-6.06%	-5.73%	分
67	小方制药	-6.13%	-5.17%	4.3分
68	-	-6.20%	-6.58%	分
69	国邦医药	-6.51%	-2.63%	4.7分
70	必贝特	-6.95%	0.09%	6.0分
71	华北制药	-7.17%	-4.04%	4.4分
72	山河药辅	-7.23%	-4.89%	4.5分
73	民生健康	-7.32%	-5.50%	4.5分
74	首药控股	-7.43%	0.45%	6.0分
75	ST人福	-7.48%	-4.20%	4.7分
76	北陆药业	-7.59%	-1.67%	5.0分
77	金城医药	-7.74%	-4.62%	5.3分
78	辰欣药业	-7.96%	-4.75%	4.5分
79	亚太药业	-8.22%	1.11%	5.0分
80	金陵药业	-8.48%	-5.66%	4.9分
81	ST能特	-8.51%	-1.83%	4.4分
82	-	-8.73%	-8.56%	分
83	东北制药	-8.82%	-5.57%	4.6分
84	汇宇制药	-8.83%	-4.66%	5.0分
85	同和药业	-8.87%	-9.39%	4.8分
86	海普瑞	-8.92%	-3.34%	5.3分
87	苑东生物	-9.14%	-1.10%	4.8分
88	天新药业	-9.22%	-4.05%	4.7分
89	恩华药业	-9.24%	-1.63%	4.8分
90	ST诺泰	-9.46%	-2.96%	4.1分
91	亚虹医药	-9.49%	-1.20%	4.4分
92	-	-9.63%	-9.54%	分
93	福元医药	-9.66%	-2.86%	5.1分
94	誉衡药业	-9.70%	-0.74%	5.6分
95	华海药业	-9.83%	-1.97%	4.9分
96	上海谊众	-9.87%	-1.95%	4.7分
97	华邦健康	-10.27%	-5.98%	4.1分
98	华纳药厂	-10.71%	-3.38%	4.5分
99	亿帆医药	-10.86%	-6.49%	4.6分
100	德展健康	-11.14%	-5.02%	4.3分
101	海森药业	-11.48%	-9.74%	4.0分
102	浙江医药	-11.56%	-3.96%	4.5分
103	北大医药	-11.75%	-8.61%	4.0分
104	哈药股份	-11.80%	-6.27%	4.7分
105	罗欣药业	-11.93%	-6.80%	5.0分
106	丰原药业	-12.02%	-6.83%	4.6分
107	一品红	-12.08%	2.93%	6.1分
108	立方制药	-12.17%	-5.47%	5.1分
109	川宁生物	-12.27%	-7.78%	4.3分
110	国药现代	-12.35%	-5.24%	4.6分
111	尔康制药	-12.47%	-6.52%	4.5分
112	海翔药业	-12.69%	-0.38%	4.6分
113	康芝药业	-12.72%	-8.67%	4.4分
114	哈三联	-13.15%	-10.35%	4.4分
115	新天地	-13.28%	-6.22%	4.6分
116	福安药业	-13.33%	-6.11%	4.6分
117	健友股份	-13.57%	-1.53%	5.1分
118	华仁药业	-13.59%	-7.81%	4.7分
119	宣泰医药	-13.66%	-3.22%	5.3分
120	鲁抗医药	-14.02%	-7.97%	4.5分
121	卫信康	-14.09%	-7.15%	4.9分
122	-	-14.17%	-18.05%	分
123	海创药业	-14.22%	-1.15%	5.3分
124	润都股份	-14.23%	-7.53%	5.1分
125	津药药业	-14.66%	-2.82%	5.0分
126	易明医药	-14.75%	-12.62%	4.8分
127	神奇制药	-14.78%	-9.02%	5.3分
128	赛托生物	-14.80%	-6.88%	5.1分
129	宏源药业	-15.03%	-9.58%	4.9分
130	永安药业	-15.17%	-10.68%	4.7分
131	向日葵	-15.29%	-7.99%	3.4分
132	溢多利	-15.36%	-7.87%	4.8分
133	富士莱	-16.23%	-8.74%	4.4分
134	拓新药业	-16.38%	-9.57%	3.9分
135	本立科技	-16.51%	-7.59%	4.3分
136	西点药业	-17.02%	-10.05%	4.3分
137	九典制药	-17.47%	-5.14%	3.9分
138	联环药业	-17.67%	-9.97%	4.4分
139	迪哲医药	-17.86%	3.90%	6.2分
140	通化金马	-18.25%	-19.87%	4.6分
141	ST天圣	-18.91%	-8.79%	3.6分
142	汉商集团	-19.43%	-10.83%	4.6分
143	奥翔药业	-20.12%	-6.07%	4.5分
144	莎普爱思	-20.54%	-10.10%	4.4分
145	广济药业	-20.99%	-13.00%	4.4分
146	中哲精化	-21.85%	-10.28%	5.0分
147	冀衡医药	-22.09%	-6.94%	4.1分
148	景峰医药	-22.22%	0.55%	4.8分
149	昂利康	-22.82%	-12.26%	4.2分
150	ST复华	-24.01%	-13.76%	3.4分
151	东亚药业	-24.82%	-4.04%	4.7分
152	多瑞医药	-25.31%	-14.22%	3.8分
153	仟源医药	-25.49%	-11.39%	4.5分
154	悦康药业	-26.81%	-6.13%	4.5分
155	ST南新	-27.34%	-5.97%	4.7分
156	美诺华	-30.14%	-13.50%	3.7分
157	博瑞医药	-31.73%	-7.43%	4.6分
158	常山药业	-40.26%	-12.48%	4.5分
159	赛隆退	-97.29%	-96.20%	3.8分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.1基本面打败了58%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（80分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 12/218 ， 109/218。

[{"date":"2026-03-31","value":"4.57","vol":"0.43"},{"date":"2025-12-31","value":"18.47","vol":"-2.03"},{"date":"2025-09-30","value":"14.19","vol":"1.53"},{"date":"2025-06-30","value":"10.18","vol":"1.24"},{"date":"2025-03-31","value":"5.08","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	4.57	18.47	14.19	10.18	5.08
行业(%)	0.43	-2.03	1.53	1.24	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"32.29","vol":"50.72"},{"date":"2025-12-31","value":"31.75","vol":"49.72"},{"date":"2025-09-30","value":"31.88","vol":"49.60"},{"date":"2025-06-30","value":"32.32","vol":"49.57"},{"date":"2025-03-31","value":"32.36","vol":"49.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	32.29	31.75	31.88	32.32	32.36
行业(%)	50.72	49.72	49.60	49.57	49.06

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 59/218 ， 72/218。

[{"date":"2026-03-31","value":"5.45","vol":"25.51"},{"date":"2025-12-31","value":"6.82","vol":"38.97"},{"date":"2025-09-30","value":"8.09","vol":"141.63"},{"date":"2025-06-30","value":"4.65","vol":"78.56"},{"date":"2025-03-31","value":"4.28","vol":"0.01"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	5.45	6.82	8.09	4.65	4.28
行业(%)	25.51	38.97	141.63	78.56	0.01

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-0.25","vol":"47.13"},{"date":"2025-12-31","value":"47.84","vol":"-26.11"},{"date":"2025-09-30","value":"8.28","vol":"-2.93"},{"date":"2025-06-30","value":"-2.61","vol":"59.61"},{"date":"2025-03-31","value":"-5.30","vol":"-10.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-0.25	47.84	8.28	-2.61	-5.30
行业(%)	47.13	-26.11	-2.93	59.61	-10.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 28/218 ， 5/218。

[{"date":"2026-03-31","value":"0.15","vol":"0.10"},{"date":"2025-12-31","value":"0.58","vol":"0.41"},{"date":"2025-09-30","value":"0.44","vol":"0.31"},{"date":"2025-06-30","value":"0.30","vol":"0.21"},{"date":"2025-03-31","value":"0.16","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.15	0.58	0.44	0.30	0.16
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.94","vol":"0.65"},{"date":"2025-12-31","value":"7.11","vol":"2.58"},{"date":"2025-09-30","value":"5.56","vol":"1.93"},{"date":"2025-06-30","value":"3.59","vol":"1.29"},{"date":"2025-03-31","value":"1.97","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	1.94	7.11	5.56	3.59	1.97
行业(次)	0.65	2.58	1.93	1.29	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"5.54","vol":"-2.81"},{"date":"2025-12-31","value":"36.10","vol":"16.49"},{"date":"2025-09-30","value":"10.10","vol":"4.26"},{"date":"2025-06-30","value":"38.88","vol":"2.95"},{"date":"2025-03-31","value":"-2.59","vol":"-26.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	5.54	36.10	10.10	38.88	-2.59
行业	-2.81	16.49	4.26	2.95	-26.33

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.75","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.73","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.75	-	0.73	-
行业	0.00	1.60	0.00	1.71	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 115/218 ， 122/218。

[{"date":"2026-03-31","value":"4.39","vol":"3.57"},{"date":"2025-12-31","value":"4.14","vol":"3.31"},{"date":"2025-09-30","value":"4.58","vol":"3.48"},{"date":"2025-06-30","value":"4.32","vol":"3.66"},{"date":"2025-03-31","value":"4.94","vol":"3.57"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	4.39	4.14	4.58	4.32	4.94
行业	3.57	3.31	3.48	3.66	3.57

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"3.99","vol":"2.93"},{"date":"2025-12-31","value":"3.75","vol":"2.69"},{"date":"2025-09-30","value":"4.15","vol":"2.73"},{"date":"2025-06-30","value":"3.87","vol":"2.88"},{"date":"2025-03-31","value":"4.44","vol":"2.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	3.99	3.75	4.15	3.87	4.44
行业	2.93	2.69	2.73	2.88	2.80

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 46/218 ， 58/218。

[{"date":"2026-03-31","value":"36.15","vol":"33.54"},{"date":"2025-12-31","value":"37.32","vol":"34.70"},{"date":"2025-09-30","value":"36.45","vol":"34.06"},{"date":"2025-06-30","value":"37.70","vol":"34.12"},{"date":"2025-03-31","value":"35.72","vol":"34.09"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	36.15	37.32	36.45	37.70	35.72
行业(%)	33.54	34.70	34.06	34.12	34.09

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.60","vol":"9.77"},{"date":"2025-12-31","value":"0.64","vol":"1.76"},{"date":"2025-09-30","value":"0.62","vol":"1.19"},{"date":"2025-06-30","value":"0.65","vol":"0.87"},{"date":"2025-03-31","value":"0.60","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.60	0.64	0.62	0.65	0.60
行业(%)	9.77	1.76	1.19	0.87	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
中信证券	2026-06-08	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"1.31","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.62","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.19","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.77","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"1.93","blueLineValue":"0.82","type":"YC"}]

[山河药辅]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]